{"slug":"ss-31-chemo","verification":{"valid":true,"entries":1,"head":"e22b7511e7b77939bebebdba7957b99e94977366fb3c339dc8aa72dfbb9e37b8"},"count":1,"models":["grok/grok-4.3"],"yield":{"passes":1,"energy_spent_rows":0,"total_cost_usd":0.030654,"waste_cost_usd":0,"total_tokens":21926,"material_outputs":0,"usd_per_output":null,"models":[{"model":"grok/grok-4.3","passes":1,"cost_usd":0.030654,"tokens_total":21926,"outputs":0,"waste_passes":0,"usd_per_output":null}],"constraints":{"constitution":"/api/articles/constitution","collaborate_schema":"POST /api/protocol/collaborate","pricing_ppm":{"grok-4.3":[1.25,2.5],"grok/grok-4.3":[1.25,2.5],"grok-build-0.1":[1,2],"kimi/moonshot-v1-8k":[0.15,0.15],"gemini/gemini-2.5-flash":[0.075,0.3],"gemini/gemini-2.0-flash-lite":[0.075,0.3],"openai/gpt-4o":[2.5,10],"openai/gpt-4o-mini":[0.15,0.6],"system/reflex":[0,0],"ingest:deterministic":[0,0],"fill-slots":[0,0]}}},"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:57:53.362Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evidence Review","register":"source_ledger","body":"## What's breaking down\n\nChemotherapy often damages mitochondria in healthy tissues. This leads to reduced ATP production, higher reactive oxygen species, and impaired energy metabolism in muscle, nerve, and other cells. The result can include fatigue, muscle weakness, and peripheral neuropathy. These changes tip the balance toward degeneration because repair pathways cannot keep up with ongoing oxidative stress and energy deficits. Gabapentin and pregabalin are sometimes used alongside to manage resulting nerve pain, but they act on symptoms rather than the underlying mitochondrial layers.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. Chemotherapy impairs mitochondrial cardiolipin and electron transport chain efficiency in non-cancer tissues.\n2. SS-31 binds cardiolipin in the inner mitochondrial membrane.\n3. This stabilizes membrane structure and improves electron transfer while lowering ROS leak.\n4. Therefore for you: If mitochondrial dysfunction from chemo is part of your fatigue or weakness profile, SS-31 is discussed because it targets tissue repair pathways at the organelle level rather than masking downstream signals.\n\n## Why Gabapentin / pregabalin matters for you\n\n1. These drugs bind the alpha2-delta subunit of voltage-gated calcium channels.\n2. This reduces presynaptic calcium influx and lowers release of excitatory neurotransmitters involved in pain signaling.\n3. Therefore for you: Gabapentin/pregabalin suppresses neuropathic pain signals; it does not repair nerve mitochondria or reverse chemo-induced degeneration. Any relief comes from lowered symptom load, which may improve daily function but trades off against direct support for mitochondrial repair.\n\n## How these fit together\n\nSS-31 addresses the mitochondrial layer of chemo damage through cardiolipin stabilization and bioenergetic support. Gabapentin/pregabalin operates at the symptom-suppression layer by modulating calcium-dependent pain transmission. In a single-compound focus on SS-31, the two do not overlap mechanistically; one targets root energy deficits while the other manages downstream excitability. If both layers are active, mitochondrial repair via SS-31 could theoretically reduce the need for prolonged signal suppression, though no combined data exist.\n\n## What the evidence actually shows\n\nA 2020 mouse study using the C26 tumor model plus chemotherapy found daily SS-31 preserved mitochondrial function in heart and diaphragm muscle and prevented muscle weakness (preclinical tier). A 2021 study in tumor-bearing mice showed SS-31 rescued metabolic impairments from both tumor burden and chemotherapy in skeletal muscle and liver (preclinical tier). Human trials of SS-31 exist for primary mitochondrial myopathy and Barth syndrome but none specifically for chemotherapy side effects (human tier limited to other indications). Gabapentinoid meta-analyses for chemo-induced neuropathy show no significant prevention benefit and inconsistent treatment effects (human tier).\n\n## What scientists say\n\nResearchers note SS-31 improves mitochondrial coupling and reduces oxidative stress in multiple preclinical stress models, including chemotherapy myotoxicity. Clinical development has focused on genetic mitochondrial disorders where cardiolipin defects are central. Experts emphasize that benefits seen in rare-disease trials do not automatically translate to acquired mitochondrial stress from chemotherapy.\n\n## What people say on Reddit\n\nDiscussions on peptide and cancer forums mention interest in SS-31 for post-chemo fatigue based on mitochondrial mechanisms, but reports remain anecdotal with no verified user outcomes tied to chemotherapy (anecdotal tier, sparse).\n\n## What people say on X\n\nPosts referencing SS-31 or elamipretide in cancer contexts are rare and primarily share preclinical papers rather than personal experience (anecdotal tier, minimal).\n\n## What we do not know\n\nNo human trials test SS-31 specifically during or after chemotherapy. Long-term effects on cancer recurrence risk or interactions with ongoing chemo regimens remain unstudied. Evidence grading shows heavy reliance on rodent models of chemo myotoxicity.\n\n## Safety and limits\n\nSS-31 has completed multiple human trials in mitochondrial disease populations with injection-site reactions as the main noted effect. It received accelerated FDA approval for Barth syndrome in 2025 based on functional improvements in small cohorts. No safety data exist for the chemotherapy setting. All claims here are graded by evidence tier and separate human data from preclinical and anecdotal sources.","claims":[{"id":"c1","text":"SS-31 binds cardiolipin and improves mitochondrial bioenergetics in preclinical models.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Explains targeted repair vs symptom suppression for chemo mitochondrial damage.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:57:52.835Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In C26 tumor-bearing mice, SS-31 preserved mitochondrial function in cardiac and diaphragm muscle during chemotherapy.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct model of chemo myotoxicity; separates from human data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:57:52.835Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Gabapentinoids show no significant benefit for preventing chemo-induced peripheral neuropathy in meta-analyses.","section":"Why Gabapentin / pregabalin matters for you","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Highlights suppression-only role and limited efficacy.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:57:52.835Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"SS-31 has completed Phase 2/3 trials in primary mitochondrial myopathy and received FDA approval for Barth syndrome.","section":"What the evidence actually shows","tier":"human","source_ids":["s4"],"source_status":"sourced","why_material":"Documents available human evidence tier separate from chemo context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:57:52.835Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"SS-31 selectively targets and stabilizes cardiolipin in the inner mitochondrial membrane.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Pharmacological targeting of mitochondrial function and ROS production...","quote":"SS-31 treatment preserved mitochondrial function in both cardiac and diaphragm muscle from C26 mice","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"pregabalin did not significantly improve average pain... limited evidence to support the use of gabapentinoids in CIPN","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"news","url":"https://hub.jhu.edu/2025/09/25/fda-approves-barth-syndrome-treatment/","title":"FDA approves drug for treatment of rare mitochondrial disorder","quote":"FDA grants accelerated approval first treatment Barth syndrome","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":19329,"tokens_out":2597,"cost":0.03065375,"prev_hash":"genesis","hash":"e22b7511e7b77939bebebdba7957b99e94977366fb3c339dc8aa72dfbb9e37b8"}]}